Evaluation of the flow cytometric crossmatch : Preliminary results of a multicenter study

The flow cytometric crossmatch is a technique that is increasingly being used by clinical transplant laboratories. In this multicenter study by the British Society for Histocompatibility and Immunogenetics Flow Cytometry Group, a series of crossmatches were carried out to determine whether different...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Transplantation 1996-04, Vol.61 (7), p.1108-1111
Hauptverfasser: HARMER, A. W, GARNER, S, REYNOLDS, W. M, ROBSON, A, SUTTON, M, VAN DAM, M. G, SHENTON, B. K, BELL, A. E, ANYANWU, C, CAVANAGH, G, CULKIN, J, EVANS, P. R, HORSBURGH, T, MARTIN, S, MCCLOSKEY, D
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1111
container_issue 7
container_start_page 1108
container_title Transplantation
container_volume 61
creator HARMER, A. W
GARNER, S
REYNOLDS, W. M
ROBSON, A
SUTTON, M
VAN DAM, M. G
SHENTON, B. K
BELL, A. E
ANYANWU, C
CAVANAGH, G
CULKIN, J
EVANS, P. R
HORSBURGH, T
MARTIN, S
MCCLOSKEY, D
description The flow cytometric crossmatch is a technique that is increasingly being used by clinical transplant laboratories. In this multicenter study by the British Society for Histocompatibility and Immunogenetics Flow Cytometry Group, a series of crossmatches were carried out to determine whether different centers obtained same results when performing the same crossmatch. There was greater than 80% agreement among participating laboratories on the results of 35/54 tests. There was no clear agreement in the remaining 20 cases. Quantitative analysis, estimating the number of cell-bound fluorescein molecules, demonstrated that differences in the criteria used by each center to define a positive crossmatch were responsible for some discordant results. When applied, definition of positivity based on the molecules of fluorescein increased concordance from 57.5% to 81.4%.l. These results suggest that a criterion for the interpretation of results based on quantitative analysis of bound antibody may be more reliable than methods in current routine use.
doi_str_mv 10.1097/00007890-199604150-00021
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78018460</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78018460</sourcerecordid><originalsourceid>FETCH-LOGICAL-c284t-e3657c192137b3c29385a35fabcc7d7540b69261242e78fa3c413496fe2a20f23</originalsourceid><addsrcrecordid>eNo9kEtLAzEUhYMotVZ_gpCFuBvNa_JwJ1IfUNCFLlyFTJrQkXnUJKP035u2Y7NJyDnnXs4HAMToBiMlblE-QipUYKU4YrhERf4h-AhMcUlZwZFEx2CKslRgSsUpOIvxK1tKKsQETCQnFCs2BZ_zH9MMJtV9B3sP08pB3_S_0G5S37oUagtt6GNsTbIreAffgmvqtu5M2MDg4tCkuM0Z2OZnbV2XXIAxDcvNOTjxponuYrxn4ONx_v7wXCxen14e7heFJZKlwlFeCosVwVRU1BJFZWlo6U1lrViKkqGKK8IxYcQJ6Q21DFOmuHfEEOQJnYHr_dx16L8HF5Nu62hd05jO9UPUQiIsGUfZKPfGXaHgvF6Hus1FNEZ6S1X_U9UHqnpHNUcvxx1D1brlIThizPrVqJtoTeOD6WwdDzaKuGQloX-A-38o</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78018460</pqid></control><display><type>article</type><title>Evaluation of the flow cytometric crossmatch : Preliminary results of a multicenter study</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>HARMER, A. W ; GARNER, S ; REYNOLDS, W. M ; ROBSON, A ; SUTTON, M ; VAN DAM, M. G ; SHENTON, B. K ; BELL, A. E ; ANYANWU, C ; CAVANAGH, G ; CULKIN, J ; EVANS, P. R ; HORSBURGH, T ; MARTIN, S ; MCCLOSKEY, D</creator><creatorcontrib>HARMER, A. W ; GARNER, S ; REYNOLDS, W. M ; ROBSON, A ; SUTTON, M ; VAN DAM, M. G ; SHENTON, B. K ; BELL, A. E ; ANYANWU, C ; CAVANAGH, G ; CULKIN, J ; EVANS, P. R ; HORSBURGH, T ; MARTIN, S ; MCCLOSKEY, D</creatorcontrib><description>The flow cytometric crossmatch is a technique that is increasingly being used by clinical transplant laboratories. In this multicenter study by the British Society for Histocompatibility and Immunogenetics Flow Cytometry Group, a series of crossmatches were carried out to determine whether different centers obtained same results when performing the same crossmatch. There was greater than 80% agreement among participating laboratories on the results of 35/54 tests. There was no clear agreement in the remaining 20 cases. Quantitative analysis, estimating the number of cell-bound fluorescein molecules, demonstrated that differences in the criteria used by each center to define a positive crossmatch were responsible for some discordant results. When applied, definition of positivity based on the molecules of fluorescein increased concordance from 57.5% to 81.4%.l. These results suggest that a criterion for the interpretation of results based on quantitative analysis of bound antibody may be more reliable than methods in current routine use.</description><identifier>ISSN: 0041-1337</identifier><identifier>EISSN: 1534-6080</identifier><identifier>DOI: 10.1097/00007890-199604150-00021</identifier><identifier>PMID: 8623194</identifier><identifier>CODEN: TRPLAU</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott</publisher><subject>Biological and medical sciences ; Flow Cytometry ; Histocompatibility Testing ; Humans ; Investigative techniques, diagnostic techniques (general aspects) ; Medical sciences ; Miscellaneous. Technology ; Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques</subject><ispartof>Transplantation, 1996-04, Vol.61 (7), p.1108-1111</ispartof><rights>1996 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c284t-e3657c192137b3c29385a35fabcc7d7540b69261242e78fa3c413496fe2a20f23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3068452$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8623194$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>HARMER, A. W</creatorcontrib><creatorcontrib>GARNER, S</creatorcontrib><creatorcontrib>REYNOLDS, W. M</creatorcontrib><creatorcontrib>ROBSON, A</creatorcontrib><creatorcontrib>SUTTON, M</creatorcontrib><creatorcontrib>VAN DAM, M. G</creatorcontrib><creatorcontrib>SHENTON, B. K</creatorcontrib><creatorcontrib>BELL, A. E</creatorcontrib><creatorcontrib>ANYANWU, C</creatorcontrib><creatorcontrib>CAVANAGH, G</creatorcontrib><creatorcontrib>CULKIN, J</creatorcontrib><creatorcontrib>EVANS, P. R</creatorcontrib><creatorcontrib>HORSBURGH, T</creatorcontrib><creatorcontrib>MARTIN, S</creatorcontrib><creatorcontrib>MCCLOSKEY, D</creatorcontrib><title>Evaluation of the flow cytometric crossmatch : Preliminary results of a multicenter study</title><title>Transplantation</title><addtitle>Transplantation</addtitle><description>The flow cytometric crossmatch is a technique that is increasingly being used by clinical transplant laboratories. In this multicenter study by the British Society for Histocompatibility and Immunogenetics Flow Cytometry Group, a series of crossmatches were carried out to determine whether different centers obtained same results when performing the same crossmatch. There was greater than 80% agreement among participating laboratories on the results of 35/54 tests. There was no clear agreement in the remaining 20 cases. Quantitative analysis, estimating the number of cell-bound fluorescein molecules, demonstrated that differences in the criteria used by each center to define a positive crossmatch were responsible for some discordant results. When applied, definition of positivity based on the molecules of fluorescein increased concordance from 57.5% to 81.4%.l. These results suggest that a criterion for the interpretation of results based on quantitative analysis of bound antibody may be more reliable than methods in current routine use.</description><subject>Biological and medical sciences</subject><subject>Flow Cytometry</subject><subject>Histocompatibility Testing</subject><subject>Humans</subject><subject>Investigative techniques, diagnostic techniques (general aspects)</subject><subject>Medical sciences</subject><subject>Miscellaneous. Technology</subject><subject>Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques</subject><issn>0041-1337</issn><issn>1534-6080</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kEtLAzEUhYMotVZ_gpCFuBvNa_JwJ1IfUNCFLlyFTJrQkXnUJKP035u2Y7NJyDnnXs4HAMToBiMlblE-QipUYKU4YrhERf4h-AhMcUlZwZFEx2CKslRgSsUpOIvxK1tKKsQETCQnFCs2BZ_zH9MMJtV9B3sP08pB3_S_0G5S37oUagtt6GNsTbIreAffgmvqtu5M2MDg4tCkuM0Z2OZnbV2XXIAxDcvNOTjxponuYrxn4ONx_v7wXCxen14e7heFJZKlwlFeCosVwVRU1BJFZWlo6U1lrViKkqGKK8IxYcQJ6Q21DFOmuHfEEOQJnYHr_dx16L8HF5Nu62hd05jO9UPUQiIsGUfZKPfGXaHgvF6Hus1FNEZ6S1X_U9UHqnpHNUcvxx1D1brlIThizPrVqJtoTeOD6WwdDzaKuGQloX-A-38o</recordid><startdate>19960415</startdate><enddate>19960415</enddate><creator>HARMER, A. W</creator><creator>GARNER, S</creator><creator>REYNOLDS, W. M</creator><creator>ROBSON, A</creator><creator>SUTTON, M</creator><creator>VAN DAM, M. G</creator><creator>SHENTON, B. K</creator><creator>BELL, A. E</creator><creator>ANYANWU, C</creator><creator>CAVANAGH, G</creator><creator>CULKIN, J</creator><creator>EVANS, P. R</creator><creator>HORSBURGH, T</creator><creator>MARTIN, S</creator><creator>MCCLOSKEY, D</creator><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19960415</creationdate><title>Evaluation of the flow cytometric crossmatch : Preliminary results of a multicenter study</title><author>HARMER, A. W ; GARNER, S ; REYNOLDS, W. M ; ROBSON, A ; SUTTON, M ; VAN DAM, M. G ; SHENTON, B. K ; BELL, A. E ; ANYANWU, C ; CAVANAGH, G ; CULKIN, J ; EVANS, P. R ; HORSBURGH, T ; MARTIN, S ; MCCLOSKEY, D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c284t-e3657c192137b3c29385a35fabcc7d7540b69261242e78fa3c413496fe2a20f23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Biological and medical sciences</topic><topic>Flow Cytometry</topic><topic>Histocompatibility Testing</topic><topic>Humans</topic><topic>Investigative techniques, diagnostic techniques (general aspects)</topic><topic>Medical sciences</topic><topic>Miscellaneous. Technology</topic><topic>Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>HARMER, A. W</creatorcontrib><creatorcontrib>GARNER, S</creatorcontrib><creatorcontrib>REYNOLDS, W. M</creatorcontrib><creatorcontrib>ROBSON, A</creatorcontrib><creatorcontrib>SUTTON, M</creatorcontrib><creatorcontrib>VAN DAM, M. G</creatorcontrib><creatorcontrib>SHENTON, B. K</creatorcontrib><creatorcontrib>BELL, A. E</creatorcontrib><creatorcontrib>ANYANWU, C</creatorcontrib><creatorcontrib>CAVANAGH, G</creatorcontrib><creatorcontrib>CULKIN, J</creatorcontrib><creatorcontrib>EVANS, P. R</creatorcontrib><creatorcontrib>HORSBURGH, T</creatorcontrib><creatorcontrib>MARTIN, S</creatorcontrib><creatorcontrib>MCCLOSKEY, D</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Transplantation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>HARMER, A. W</au><au>GARNER, S</au><au>REYNOLDS, W. M</au><au>ROBSON, A</au><au>SUTTON, M</au><au>VAN DAM, M. G</au><au>SHENTON, B. K</au><au>BELL, A. E</au><au>ANYANWU, C</au><au>CAVANAGH, G</au><au>CULKIN, J</au><au>EVANS, P. R</au><au>HORSBURGH, T</au><au>MARTIN, S</au><au>MCCLOSKEY, D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evaluation of the flow cytometric crossmatch : Preliminary results of a multicenter study</atitle><jtitle>Transplantation</jtitle><addtitle>Transplantation</addtitle><date>1996-04-15</date><risdate>1996</risdate><volume>61</volume><issue>7</issue><spage>1108</spage><epage>1111</epage><pages>1108-1111</pages><issn>0041-1337</issn><eissn>1534-6080</eissn><coden>TRPLAU</coden><abstract>The flow cytometric crossmatch is a technique that is increasingly being used by clinical transplant laboratories. In this multicenter study by the British Society for Histocompatibility and Immunogenetics Flow Cytometry Group, a series of crossmatches were carried out to determine whether different centers obtained same results when performing the same crossmatch. There was greater than 80% agreement among participating laboratories on the results of 35/54 tests. There was no clear agreement in the remaining 20 cases. Quantitative analysis, estimating the number of cell-bound fluorescein molecules, demonstrated that differences in the criteria used by each center to define a positive crossmatch were responsible for some discordant results. When applied, definition of positivity based on the molecules of fluorescein increased concordance from 57.5% to 81.4%.l. These results suggest that a criterion for the interpretation of results based on quantitative analysis of bound antibody may be more reliable than methods in current routine use.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott</pub><pmid>8623194</pmid><doi>10.1097/00007890-199604150-00021</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0041-1337
ispartof Transplantation, 1996-04, Vol.61 (7), p.1108-1111
issn 0041-1337
1534-6080
language eng
recordid cdi_proquest_miscellaneous_78018460
source MEDLINE; Journals@Ovid Complete
subjects Biological and medical sciences
Flow Cytometry
Histocompatibility Testing
Humans
Investigative techniques, diagnostic techniques (general aspects)
Medical sciences
Miscellaneous. Technology
Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques
title Evaluation of the flow cytometric crossmatch : Preliminary results of a multicenter study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T17%3A40%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evaluation%20of%20the%20flow%20cytometric%20crossmatch%20:%20Preliminary%20results%20of%20a%20multicenter%20study&rft.jtitle=Transplantation&rft.au=HARMER,%20A.%20W&rft.date=1996-04-15&rft.volume=61&rft.issue=7&rft.spage=1108&rft.epage=1111&rft.pages=1108-1111&rft.issn=0041-1337&rft.eissn=1534-6080&rft.coden=TRPLAU&rft_id=info:doi/10.1097/00007890-199604150-00021&rft_dat=%3Cproquest_cross%3E78018460%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78018460&rft_id=info:pmid/8623194&rfr_iscdi=true